FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (KVK-TECH, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cyclobenzaprine hydrochloride from KVK-Tech, Inc., allowing the generic product to proceed under the ANDA framework.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Conditions
• Musculoskeletal Pain

Drugs mentioned

• CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)